Q2 2024 Holdings
Filed 2024-08-14 | 39 holdings | $79.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $10.2M | 187,633 | 12.8% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $6.9M | 154,665 | 8.6% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $6.5M | 956,542 | 8.2% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $5.6M | 219,837 | 7.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $5.5M | 680,403 | 6.9% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $5.2M | 875,999 | 6.5% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $3.7M | 215,178 | 4.7% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $3.4M | 74,288 | 4.3% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $3.3M | 59,133 | 4.1% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $2.9M | 111,133 | 3.6% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $2.6M | 56,468 | 3.2% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $1.8M | 12,508 | 2.2% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $1.6M | 497,360 | 2.1% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $1.6M | 689,912 | 2.0% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $1.6M | 484,443 | 2.0% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $1.5M | 36,928 | 1.8% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $1.4M | 1,151,518 | 1.8% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $1.2M | 64,213 | 1.6% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $1.2M | 95,229 | 1.5% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $1.1M | 66,892 | 1.4% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $1.1M | 45,571 | 1.4% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $1.0M | 139,895 | 1.3% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $991.6K | 115,571 | 1.3% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $940.6K | 940,578 | 1.2% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $873.8K | 87,638 | 1.1% |
| Savara Inc(SVRA) | COM | 805111101 | $806.0K | 200,000 | 1.0% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $752.0K | 167,110 | 0.9% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $746.2K | 36,242 | 0.9% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $548.2K | 156,626 | 0.7% |
| Atyr Pharma Inc(ATYR) | COM NEW | 002120202 | $488.3K | 313,028 | 0.6% |
| Pepgen Inc(PEPG) | COM | 713317105 | $466.8K | 29,249 | 0.6% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $463.7K | 534,485 | 0.6% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $329.2K | 37,838 | 0.4% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $306.4K | 261,861 | 0.4% |
| Mersana Therapeutics Inc | COM | 59045L106 | $221.2K | 110,073 | 0.3% |
| Lakeshore Biopharma Co LTD | ORDINARY SHARES | G9845F109 | $199.5K | 307,920 | 0.3% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $196.3K | 32,497 | 0.2% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $195.0K | 37,789 | 0.2% |
| Spruce Biosciences Inc | COM | 85209E109 | $40.4K | 77,992 | 0.1% |